First Time Loading...

Bioventix PLC
LSE:BVXP

Watchlist Manager
Bioventix PLC Logo
Bioventix PLC
LSE:BVXP
Watchlist
Price: 4 325 GBX Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one BVXP stock under the Base Case scenario is 3 060.28 GBX. Compared to the current market price of 4 325 GBX, Bioventix PLC is Overvalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BVXP Relative Value
Base Case
3 060.28 GBX
Overvaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

16.6
P/S
P/S
Price to Sales
16.6
vs History
50
vs Industry
36
Median 3Y
15.9
Median 5Y
17
Industry
8.1
Forward
16
More Details
26.1
P/E
P/E
Price to Earnings
26.1
vs History
46
vs Industry
6
Median 3Y
24.3
Median 5Y
26.2
Industry
26.2
Forward
25.8
More Details
28.2
P/OCF
P/OCF
Price to OCF
28.2
vs History
20
vs Industry
6
Median 3Y
25.5
Median 5Y
25.8
Industry
22.6
More Details
28.3
P/FCFE
P/FCFE
Price to FCFE
28.3
vs History
28
vs Industry
6
Median 3Y
25.7
Median 5Y
26.3
Industry
21.3
More Details
19.7
P/B
P/B
Price to Book Value
19.7
vs History
11
vs Industry
4
Median 3Y
16.7
Median 5Y
16.7
Industry
2.5
More Details
16.2
EV/S
EV/S
Enterprise Value to Sales
16.2
vs History
49
vs Industry
31
Median 3Y
15.4
Median 5Y
16.6
Industry
7.3
Forward
15.6
More Details
17.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
17.3
vs History
52
vs Industry
29
Median 3Y
16.4
Median 5Y
17.7
Industry
9.1
More Details
20.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.3
vs History
52
vs Industry
6
Median 3Y
19.4
Median 5Y
20.7
Industry
4.4
Forward
19.3
More Details
20.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.5
vs History
53
vs Industry
6
Median 3Y
19.7
Median 5Y
21
Industry
4.3
Forward
19.5
More Details
27.5
EV/OCF
EV/OCF
Enterprise Value to OCF
27.5
vs History
19
vs Industry
6
Median 3Y
24.7
Median 5Y
25
Industry
5.4
More Details
27.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.6
vs History
26
vs Industry
6
Median 3Y
25
Median 5Y
25.4
Industry
3.2
More Details
37.1
EV/IC
EV/IC
Enterprise Value to IC
37.1
vs History
41
vs Industry
8
Median 3Y
33.9
Median 5Y
36.5
Industry
5
More Details

Multiples Across Competitors

BVXP Competitors Multiples
Bioventix PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Bioventix PLC
LSE:BVXP
225.8m GBP 16.6 26.1 20.3 20.5
US
Abbvie Inc
NYSE:ABBV
284B USD 5.2 58.9 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
149.1B USD 5.3 22.2 16.5 24.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.1B USD 10.4 28.5 22.8 23.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
102.6B USD 7.8 25.9 17.4 19.1
AU
CSL Ltd
ASX:CSL
133B AUD 6.2 35.4 21.4 26.6
US
Gilead Sciences Inc
NASDAQ:GILD
81.4B USD 3 168.2 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
48B USD 7 -10.2 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.1B USD 3.2 26.6 13.7 17.1
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
BVXP intrinsic value, competitors valuation, and company profile.
DCF Valuation
BVXP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BVXP stock valuation using valuation multiples.
Wall Street Estimates
BVXP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BVXP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.